Silo Pharma Stock Buy Hold or Sell Recommendation
| SILO Stock | USD 1.39 0.08 6.11% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Silo Pharma is 'Strong Sell'. The recommendation algorithm takes into account all of Silo Pharma's available fundamental, technical, and predictive indicators you will find on this site.
Check out Silo Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Silo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Silo Pharma. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Silo |
Execute Silo Pharma Buy or Sell Advice
The Silo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Silo Pharma. Macroaxis does not own or have any residual interests in Silo Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Silo Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Silo Pharma Trading Alerts and Improvement Suggestions
| Silo Pharma is way too risky over 90 days horizon | |
| Silo Pharma may become a speculative penny stock | |
| Silo Pharma appears to be risky and price may revert if volatility continues | |
| Silo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Silo Pharma Returns Distribution Density
The distribution of Silo Pharma's historical returns is an attempt to chart the uncertainty of Silo Pharma's future price movements. The chart of the probability distribution of Silo Pharma daily returns describes the distribution of returns around its average expected value. We use Silo Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Silo Pharma returns is essential to provide solid investment advice for Silo Pharma.
| Mean Return | 0.84 | Value At Risk | -8.7 | Potential Upside | 11.11 | Standard Deviation | 8.90 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Silo Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Silo Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Silo Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Silo Pharma's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Silo otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.84 | |
β | Beta against Dow Jones | -0.46 | |
σ | Overall volatility | 9.33 | |
Ir | Information ratio | 0.09 |
Silo Pharma Volatility Alert
Silo Pharma is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Silo Pharma's otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Silo Pharma's otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Silo Pharma Fundamentals Vs Peers
Comparing Silo Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Silo Pharma's direct or indirect competition across all of the common fundamentals between Silo Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Silo Pharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Silo Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Silo Pharma to competition |
| Fundamentals | Silo Pharma | Peer Average |
| Return On Equity | -0.44 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Operating Margin | (53.47) % | (5.51) % |
| Current Valuation | (2.06 M) | 16.62 B |
| Shares Outstanding | 2.84 M | 571.82 M |
| Shares Owned By Insiders | 6.34 % | 10.09 % |
| Shares Owned By Institutions | 5.60 % | 39.21 % |
| Number Of Shares Shorted | 61.39 K | 4.71 M |
| Price To Earning | 118.39 X | 28.72 X |
| Price To Book | 0.93 X | 9.51 X |
| Price To Sales | 77.69 X | 11.42 X |
| Revenue | 72.1 K | 9.43 B |
| Gross Profit | 66.26 K | 27.38 B |
| EBITDA | (3.86 M) | 3.9 B |
| Net Income | (3.63 M) | 570.98 M |
| Cash And Equivalents | 8.85 M | 2.7 B |
| Cash Per Share | 4.45 X | 5.01 X |
| Current Ratio | 33.28 X | 2.16 X |
| Book Value Per Share | 2.12 X | 1.93 K |
| Cash Flow From Operations | (3.22 M) | 971.22 M |
| Short Ratio | 0.46 X | 4.00 X |
| Earnings Per Share | (1.18) X | 3.12 X |
| Target Price | 10.0 | |
| Number Of Employees | 3 | 18.84 K |
| Beta | 1.35 | -0.15 |
| Market Capitalization | 5.6 M | 19.03 B |
| Total Asset | 7.75 M | 29.47 B |
| Retained Earnings | (10.87 M) | 9.33 B |
| Working Capital | 6.91 M | 1.48 B |
| Net Asset | 7.75 M |
Note: Insider Trading [view details]
Silo Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Silo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Silo Pharma Buy or Sell Advice
When is the right time to buy or sell Silo Pharma? Buying financial instruments such as Silo OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Silo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Video Games Thematic Idea Now
Video Games
Companies that are involved in the building and marketing of video games or gaming software. The Video Games theme has 22 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Video Games Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.